Updated Date:
23 Jun 2026
Product Detail:
DANTRIUM dantrolene sodium hemiheptahydrate 20mg powder for injection vial
Shortage Status:
Anticipated
AUST R:
14435
Availability:
Available
Active Ingredient:
dantrolene sodium hemiheptahydrate
Reason:
Unexpected increase in consumer demand
Dosage Form:
Injection,powderfor
Supply Impact Dates
From 10 Jul 2026
To 15 Sep 2026
Management Action:
The sponsor is working to expedite the next shipment. An overseas-registered product has been approved for supply under section 19A. The approval holder, ORSPEC Pharma Pty Ltd, can be contacted for details on supply on 02 4339 4239.